RYSGX
Price
$58.69
Change
+$3.80 (+6.92%)
Updated
Feb 3 closing price
Net Assets
5.4M
VEXRX
Price
$111.06
Change
-$1.83 (-1.62%)
Updated
Feb 3 closing price
Net Assets
20.23B
Interact to see
Advertisement

RYSGX vs VEXRX

Header iconRYSGX vs VEXRX Comparison
Open Charts RYSGX vs VEXRXBanner chart's image
Rydex S&P SmallCap 600 Pure Growth A
Price$58.69
Change+$3.80 (+6.92%)
VolumeN/A
Net Assets5.4M
Vanguard Explorer Adm
Price$111.06
Change-$1.83 (-1.62%)
VolumeN/A
Net Assets20.23B
RYSGX vs VEXRX Comparison Chart in %
View a ticker or compare two or three
VS
RYSGX vs. VEXRX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYSGX is a Hold and VEXRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.2B vs. RYSGX (5.4M). VEXRX pays higher dividends than RYSGX: VEXRX (0.54) vs RYSGX (0.00). RYSGX was incepted earlier than VEXRX: RYSGX (21 years) vs VEXRX (24 years). RYSGX (1.60) is less costly to investors than VEXRX (0.33). RYSGX is a more actively managed with annual turnover of: 3105.00 vs. VEXRX (51.00). RYSGX has a lower initial minimum investment than VEXRX: RYSGX (2500) vs VEXRX (50000). RYSGX annual gain was more profitable for investors over the last year : 11.77 vs. VEXRX (0.66). VEXRX return over 5 years is better than : -12.97 vs. RYSGX (-35.51).
RYSGXVEXRXRYSGX / VEXRX
Total Expense Ratio1.550.33470%
Annual Report Gross Expense Ratio1.600.33485%
Fund Existence21 years24 years-
Gain YTD6.3034.096154%
Front Load5%N/A-
Min. Initial Investment2500500005%
Min. Initial Investment IRAN/AN/A-
Net Assets5.4M20.2B0%
Annual Yield % from dividends0.000.54-
Returns for 1 year11.770.661,779%
Returns for 3 years21.6413.57159%
Returns for 5 years-35.51-12.97274%
Returns for 10 years26.7172.2937%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMTX1.700.15
+9.68%
Aemetis
BBNX14.460.76
+5.55%
Beta Bionics Inc
HTCR0.26N/A
+1.96%
Heartcore Enterprises
AFRM61.66-0.33
-0.53%
Affirm Holdings
KLIC57.20-0.71
-1.23%
Kulicke and Soffa Industries